Vimarsana
Biggest News Aggregation in the World

Biocon Hulio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biocon Hulio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biocon Hulio Today - Breaking & Trending Today

Biosimilar Competition Erodes Humira's Market Share; Amjevita Leads the Pack - Vimarsana News

Biosimilar Competition Erodes Humira's Market Share; Amjevita Leads the Pack

Published: September 22, 2023

A survey of gastroenterologists, dermatologists, and rheumatologists found Amjevita had the most recognition, followed by Cyltezo, the only interchangeable biosimilar on the US market.

Source: ajmc.com
Related Topics:
United StatesBiocon HulioCoherus Bioscience YusimryBoehringer Ingelheim CyltezoSandoz HyrimozAbbvie HumiraCardinal HealthSpecial TopixBiosimilars TodaySpherix GlobalBoehringer IngelheimCoherus Bioscience
Hulio: Biosimilar Humira likely to boost US revenues for Biocon Biologics - Vimarsana News

Hulio: Biosimilar Humira likely to boost US revenues for Biocon Biologics

Published: July 4, 2023

Analysts, however, feel that together with upcoming Aspart (insulin) and vaccines, Hulio will help drive BBL's revenues from the current $1 billion to around $1.65 billion by FY25

Source: business-standard.com
Related Topics:
Biocon HulioKunal RanderiaBiocon SemgleeCoherus BiosciencesNuvama ResearchBiocon BiologicsRheumatoid ArthritisPsoriatic ArthritisAnkylosing SpondylitisUlcerative ColitisBoehringer IngelheimPreventive Action